Top Democrat, in letter, blasts Valeant CEO for lack of cooperation
The stock price of Valeant Pharmaceuticals International, Inc. is shown on a screen above the floor of the New York Stock Exchange shortly after the opening bell in New York, December 28, 2015. REUTERS/Lucas Jackson
WASHINGTON (Reuters) - A top Democrat in the U.S. House of Representatives on Tuesday called on Valeant Pharmaceuticals International Inc for more details on its relationship with Philidor RX services and chided the company for not providing Congress any documents or other requested information.
“Your refusal to cooperate fully with Congress is extremely troubling and reflects a pattern of obstruction that impairs our ability to protect the American people against your company’s exorbitant price increases," U.S. Representative Elijah Cummings wrote in a letter to Valeant Chief Executive Michael Pearson.
(Reporting by Susan Heavey)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tenable Mentioned as short at Bear Cave
- Market cuts odds of Fed hike after jobs data, but economists still see case for tightening
- Trump Administration Weighs Order On Autism And Vaccines - Bloomberg
Create E-mail Alert Related Categories
Litigation, Reuters, Short Sales, Trader TalkRelated Entities
Raising PricesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share